By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Small Business Innovation Research (SBIR) 

Regional Area      U.S.A.
Phone: 800-382-4634 Fax: 800-462-4128


Company News
Recombinant Technologies, LLC Release: Company Receives Phase II SBIR Grant To Develop AmyTrap for Treatment of Alzheimer’s Disease 1/16/2017 9:21:59 AM
Foresight Science & Technology Received Phase I SBIR To Research Novel Method Of Fire Ant Control 11/8/2016 12:42:36 PM
RadioMedix And AREVA MedSBIR NCI Contract Grant Awarded To Develop Targeted Alpha-Emitter Therapy Of Neuroendocrine Tumors With Lead-212 11/1/2016 11:04:35 AM
Cellerant Therapeutics, Inc. Awarded $1.5 Million SBIR Contract For Development Of Novel Antibody-Based Therapeutic Against IL1RAP 9/26/2016 10:57:45 AM
Abilita Bio Awarded NCI Phase-I SBIR Grant To Develop Therapeutic Antibodies Targeting Metastatic Breast Cancer 9/20/2016 10:38:22 AM
EyeGate Pharma Awarded $448,185 For Second Year Of Funding Of Phase II SBIR Grant From U.S. Department Of Defense 9/13/2016 8:10:55 AM
Plex Pharmaceuticals, Inc. Awarded $299,173 NIH Phase I SBIR Grant Funding To Find Non-Surgical Treatments For Cataracts 9/7/2016 3:13:12 PM
SAb Biotherapeutics Receives $1.42 Million SBIR Grant To Advance Influenza Treatment 9/7/2016 10:59:36 AM
Spherix (SPEX) Awarded Phase II National Science Foundation SBIR Grant To Support Commercialization Of Total Holographic Characterization 9/7/2016 9:22:28 AM
Vigilant Biosciences Awarded Phase I SBIR Grant For Next Generation Oral Cancer Diagnostic System 8/11/2016 7:24:33 AM